Generic Medicines
- All
- News
- Videos
-
No Brand Names, Prescribing Generic Drugs Should Be A Must: Supreme Court
Doctors should only prescribe generic medicines and not any particular brand, as has been ordered in Rajasthan, the Supreme Court remarked today while hearing a petition seeking regulation of unethical marketing practices by pharmaceutical companies.
-
How Trump's Tariffs On India Will Backfire On The US Healthcare System
The US relies heavily on Indian generic medicines, with nearly half of all generic drugs consumed in the US originating from India. This has resulted in significant savings for the US healthcare system.
-
Glenmark Pharmaceuticals Recalls 1,200 Bottles Of "Subpotent" Hypertension Drug In US
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
-
Doctors' Body Seeks Withdrawal Of Mandatory Prescription Of Generic Medicines
The IMA has written to Union Health Minister Mansukh Mandaviya seeking withdrawal of National Medical Commission (NMC) regulations on mandatory prescription of generic drugs till there is quality assurance of all medicines.
-
Prescribe Generic Medicines, Uttarakhand Official Tells Government Doctors
Stern action will be taken against doctors in government hospitals in Uttarakhand if they prescribe branded medicines to patients coming to hospitals instead of generic drugs, Director General Health Tripti Bahuguna said today.
-
India's Shortage Of Remdesivir Is Easing, Says Producer Cipla
India's supply of antiviral drug remdesivir and generic equivalents is stabilising after shortages of the vital COVID-19 medicine at hospitals, according to a top executive at one of the country's big drugmakers, Cipla Ltd.
-
Cipla Set To Undercut Rivals With Generic Remdesivir: Report
Sources said the first batch of 10,000 vials had been printed with a price of Rs 4,000, Rs 800 below the cheapest option, launched by European competitor Mylan this week.
-
Cipla Gets Regulatory Nod To Make Gilead's COVID-19 Drug, Shares Hit Record High
Cipla shares surged over 9% after it got an approval from DCGI to manufacture and market generic COVID-19 drug Remdesivir.
-
Hyderabad-Based Hetero Gets Regulatory Nod To Make Gilead's COVID-19 Drug
Hetero said its generic version of US-based Gilead Science's Remdesivir will be marketed under brand name Covifor in India.
-
Will Supply Drug To "Badly-Affected Nations": India After Trump Threat
India will allow limited exports of the anti-malaria drug hydroxychloroquine, which is being tested as a coronavirus cure, to "nations that have been badly affected" by the pandemic, the government said today. Hours before the announcement, US President Donald Trump had made stunning comments about "retaliation" if India declined to ship the medici...
-
"I See God In You": Dehradun Woman's Story Turns PM Modi Emotional
Prime Minister Narendra Modi turned emotional on Saturday when a woman beneficiary of his government's generic medicine programme told him that she had "seen God in you".
-
Watch: PM Modi Moved After Woman Cries, Thanks Him For Subsidised Medicines
Emotional message of thanks from beneficiary of Pradhan Mantri Bharatiya Janaushadhi Pariyojana - a central scheme that provides generic medicines at subsidised prices - left Prime Minister Narendra Modi visibly moved
-
Sun Pharma Flags Hypertension Drug Shortage Due To Supply Constraint
Indian companies are the main supplier of generic drugs to the world and procure almost 70 per centof the active pharmaceutical ingredients (APIs) for their medicines from China. The coronavirus outbreak has disrupted international businesses dependent on Chinese supplies.
-
Generic Drugmakers May Face Supply Shortages From China If Coronavirus Drags On
An important supplier of generic drugs to the world, Indian companies procure almost 70 per cent of the active pharmaceutical ingredients (APIs) for their medicines from China.
-
Generic Drugs Result In Rs 2,000 Crore Benefits For Common People: Centre
The government Tuesday said that generic drugs have resulted in benefits worth Rs 2,000 crore for common people.
-
No Brand Names, Prescribing Generic Drugs Should Be A Must: Supreme Court
Doctors should only prescribe generic medicines and not any particular brand, as has been ordered in Rajasthan, the Supreme Court remarked today while hearing a petition seeking regulation of unethical marketing practices by pharmaceutical companies.
-
How Trump's Tariffs On India Will Backfire On The US Healthcare System
The US relies heavily on Indian generic medicines, with nearly half of all generic drugs consumed in the US originating from India. This has resulted in significant savings for the US healthcare system.
-
Glenmark Pharmaceuticals Recalls 1,200 Bottles Of "Subpotent" Hypertension Drug In US
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
-
Doctors' Body Seeks Withdrawal Of Mandatory Prescription Of Generic Medicines
The IMA has written to Union Health Minister Mansukh Mandaviya seeking withdrawal of National Medical Commission (NMC) regulations on mandatory prescription of generic drugs till there is quality assurance of all medicines.
-
Prescribe Generic Medicines, Uttarakhand Official Tells Government Doctors
Stern action will be taken against doctors in government hospitals in Uttarakhand if they prescribe branded medicines to patients coming to hospitals instead of generic drugs, Director General Health Tripti Bahuguna said today.
-
India's Shortage Of Remdesivir Is Easing, Says Producer Cipla
India's supply of antiviral drug remdesivir and generic equivalents is stabilising after shortages of the vital COVID-19 medicine at hospitals, according to a top executive at one of the country's big drugmakers, Cipla Ltd.
-
Cipla Set To Undercut Rivals With Generic Remdesivir: Report
Sources said the first batch of 10,000 vials had been printed with a price of Rs 4,000, Rs 800 below the cheapest option, launched by European competitor Mylan this week.
-
Cipla Gets Regulatory Nod To Make Gilead's COVID-19 Drug, Shares Hit Record High
Cipla shares surged over 9% after it got an approval from DCGI to manufacture and market generic COVID-19 drug Remdesivir.
-
Hyderabad-Based Hetero Gets Regulatory Nod To Make Gilead's COVID-19 Drug
Hetero said its generic version of US-based Gilead Science's Remdesivir will be marketed under brand name Covifor in India.
-
Will Supply Drug To "Badly-Affected Nations": India After Trump Threat
India will allow limited exports of the anti-malaria drug hydroxychloroquine, which is being tested as a coronavirus cure, to "nations that have been badly affected" by the pandemic, the government said today. Hours before the announcement, US President Donald Trump had made stunning comments about "retaliation" if India declined to ship the medici...
-
"I See God In You": Dehradun Woman's Story Turns PM Modi Emotional
Prime Minister Narendra Modi turned emotional on Saturday when a woman beneficiary of his government's generic medicine programme told him that she had "seen God in you".
-
Watch: PM Modi Moved After Woman Cries, Thanks Him For Subsidised Medicines
Emotional message of thanks from beneficiary of Pradhan Mantri Bharatiya Janaushadhi Pariyojana - a central scheme that provides generic medicines at subsidised prices - left Prime Minister Narendra Modi visibly moved
-
Sun Pharma Flags Hypertension Drug Shortage Due To Supply Constraint
Indian companies are the main supplier of generic drugs to the world and procure almost 70 per centof the active pharmaceutical ingredients (APIs) for their medicines from China. The coronavirus outbreak has disrupted international businesses dependent on Chinese supplies.
-
Generic Drugmakers May Face Supply Shortages From China If Coronavirus Drags On
An important supplier of generic drugs to the world, Indian companies procure almost 70 per cent of the active pharmaceutical ingredients (APIs) for their medicines from China.
-
Generic Drugs Result In Rs 2,000 Crore Benefits For Common People: Centre
The government Tuesday said that generic drugs have resulted in benefits worth Rs 2,000 crore for common people.
